NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

Last Close
Apr 17 04:00PM ET
18.05
Dollar change
-0.06
Percentage change
-0.33
%
IndexRUT P/E15.36 EPS (ttm)1.18 Insider Own5.82% Shs Outstand12.21M Perf Week41.24%
Market Cap221.16M Forward P/E12.39 EPS next Y1.46 Insider Trans0.00% Shs Float11.54M Perf Month44.51%
Income14.60M PEG- EPS next Q0.29 Inst Own87.57% Short Float0.42% Perf Quarter45.84%
Sales47.26M P/S4.68 EPS this Y-24.76% Inst Trans-30.80% Short Ratio4.21 Perf Half Y39.57%
Book/sh23.64 P/B0.76 EPS next Y32.34% ROA4.38% Short Interest0.05M Perf Year39.08%
Cash/sh0.48 P/C37.30 EPS next 5Y- ROE5.13% 52W Range11.53 - 18.66 Perf YTD49.43%
Dividend Est.- P/FCF9.65 EPS past 5Y-10.11% ROI4.47% 52W High-3.25% Beta0.01
Dividend TTM- Quick Ratio- Sales past 5Y11.89% Gross Margin91.50% 52W Low56.54% ATR (14)0.68
Dividend Ex-DateApr 24, 2025 Current Ratio- EPS Y/Y TTM-5.64% Oper. Margin51.14% RSI (14)82.07 Volatility3.68% 3.20%
Employees24 Debt/Eq0.13 Sales Y/Y TTM23.75% Profit Margin30.89% Recom1.00 Target Price21.00
Option/ShortNo / Yes LT Debt/Eq0.13 EPS Q/Q109.23% Payout0.00% Rel Volume2.26 Prev Close18.11
Sales Surprise- EPS Surprise-42.46% Sales Q/Q32.45% EarningsMar 20 BMO Avg Volume11.39K Price18.05
SMA2026.33% SMA5035.38% SMA20040.26% Trades Volume25,757 Change-0.33%
Apr-10-25 04:15PM
Mar-20-25 01:45PM
Mar-19-25 09:20PM
09:10PM
Mar-13-25 07:30AM
11:00AM Loading…
Feb-07-25 11:00AM
Jan-06-25 07:35AM
Nov-14-24 04:15PM
Oct-17-24 04:15PM
Aug-15-24 08:15AM
Jul-17-24 04:15PM
Jul-08-24 05:00PM
May-19-24 08:08AM
May-15-24 10:54PM
04:05PM
05:33AM Loading…
Mar-23-24 05:33AM
Mar-21-24 01:53PM
07:00AM
Jan-23-24 04:05PM
Nov-09-23 07:30AM
Nov-06-23 04:05PM
Oct-30-23 08:00AM
Oct-18-23 08:00AM
Oct-11-23 08:00AM
Oct-03-23 04:05PM
Sep-28-23 06:34PM
Sep-26-23 04:07PM
Aug-17-23 09:00AM
Aug-09-23 04:05PM
Aug-08-23 08:00AM
05:43PM Loading…
Jul-27-23 05:43PM
Jul-17-23 04:05PM
Jun-28-23 04:05PM
May-11-23 09:00AM
07:00AM
May-02-23 04:36PM
Apr-03-23 07:30AM
Mar-31-23 08:00AM
SWK Holdings Corp. engages in financial and asset management in the field of pharmaceuticals. The company offers capital and investments in life science companies, institutions, and inventors. It operates through the Finance Receivables and Pharmaceutical Development segments. The Finance Receivables segment is a healthcare capital provider which offers customized financing solutions to a broad range of life science companies, institutions, and investors. It is primarily focused on monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. The Pharmaceutical Development segment strategy is to utilize the Peptelligence platform to create a wholly-owned portfolio of milestone and royalty income by out-licensing the technology. The company was founded in July 1996 and is headquartered in Dallas, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Staggs Joe David JRPRESIDENTApr 15 '25Option Exercise11.2233,750378,525149,623Apr 17 04:34 PM